Primary and Secondary Outcomes Authors used national Swedish electronic health registers to identify people with diagnosed depression or anxiety who used antidiabetic medication between 20092022
Fahy, G.M., Brooke, R.T., Watson, J.P., Good, Z., Vasanawala, S.S., Maecker, H., & Bhatt, N
GLP-1 receptor agonists are used in laboratory research to better understand receptor pharmacology and metabolic signaling
In the central nervous system (CNS), GLP-1s may impact neuronal function in conditions, such as Alzheimer's disease and Parkinson's disease, through multiple mechanisms
A potential concern for competitors is the delayed gastric emptying effect
I used to get the visual aura without the headache in my 20s, which is occurs to people with migraines